JANUZZI Jim, Boston, USA<br>Dr. James Januzzi is currently the Roman W. DeSanctis Endowed Distinguished Clinical Scholar in Medicine and Director of the Cardiac ICU at the Massachusetts General Hospital, and an Associate Professor of Medicine at Harvard Medical School. Dr. Januzzi has contributed greatly to the understanding of cardiac biomarker testing in patients with heart disease, where his work with the natriuretic peptides has set international standards for their use in diagnosis, prognosis, and management of patients suffering from heart failure. Additionally, Dr. Januzzi’s research group has actively studied many novel biomarkers such as ST2, galectin-3, GDF-15, and highly sensitive troponin in several populations including heart failure, acute coronary syndromes as well as apparently well patients. He has published more than
300 works, has edited two text books on cardiac biomarker testing, and is on the editorial board of numerous scientific journals, including serving as an Associate Editor for JACC: Heart Failure. He was the chairman of the NT-proBNP
Consensus Panel, is the lead author of the Heart Failure Section for the Universal Definition of MI Biomarker Task Force, and is a section editor and member of the working group for the ACC/AHA Clinical Practice Guidelines for Heart Failure.